CCNC and colonic neoplasm: On the other hand, analysis of microarray data (which is available with a longer follow-up than RNA-Seq data) in the curated SurvExpress dataset (http://bioinformatica.mty.itesm.mx:8080/Biomatec/SurvivaX.jsp) of 808 colon cancers shows that expression of CDK8 and CDK19 (but not CCNC) was progressively increased among patients separated into three risk groups according to disease-specific survival (Figure 7).